• Latest Posts

Austrian Researchers build an improved Mini-Brain to support Psychiatry

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

Novartis Negotiates its Way into the US Migraine Market

In Depth 25 Apr 2017

How Biotech is Mastering Multiple Sclerosis: A Review

New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

Interview 10 Apr 2017

“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec


UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

Galapagos finds a Partner to Boost its Pipeline with Drug Combinations

Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?

French Biotech bids for Crowdfunding in Neurodegenerative Disease

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

A Dutch University Hospital has Halted Amyloid Beta Drug Studies